Many cloud-based SaaS (software as a service) stocks have surged over the past few years as companies have pivoted from locally-installed software to subscription-based services. That's because SaaS solutions are generally easier to scale, more cost effective, and more secure than local software.
The Hartford introduced Behavioral Health and Substance Support Benefits, a new plan design option for its group hospital indemnity insurance product.
Former prime minister Theresa May urged her successor Boris Johnson to protect Britain's values to help strengthen ties with the new U.S. administration, saying his threat to break international law had done nothing to raise "our credibility". May, who said she "never knew what to expect" from U.S. President Donald Trump, described the inauguration of Joe Biden in an article in the Daily Mail newspaper as a chance for both countries to better promote democratic values. Britain's former leader was herself criticised by some opposition lawmakers for being too close to Trump after he held her hand on a visit to Washington.
In order to understand why higher interest rates impact the stock market, you need to remember what an investment is and how it is valued. The higher the discount rate you use, the less valuable the investment, and vice versa. Determining a discount rate for valuing the stock market is not an exact science, but most market participants use a combination of two inputs: the risk free rate and the equity risk premium (ERP.) The risk free rate reflects the safest investment you can make, and is generally proxied by the yield on the 10-year Treasury bond.
Company to Provide Update on Initial Success of Litigation Strategy with Four Major Entities CORSICANA, TX, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Midwest Energy Emissions Corp. (OTCQB: MEEC) ("ME2C" or the “Company”), a leading environmental technologies firm, today announced management has scheduled a shareholder update call at 11:30 AM ET on Wednesday, January 27, 2021. Richard MacPherson, President and CEO of ME2C, will provide an overview of the business model as well as an update on the initial successes of the patent litigation strategy and go-forward initiatives. The shareholder call will be accompanied by a presentation and followed by a question-and-answer session, which can be accessed via the webcast link or dial-in numbers below. To access the shareholder call, please use the following information: Date: Wednesday, January 27, 2021Time: 11:30 AM Eastern time (8:30 AM Pacific time)Dial-in: 1-866-548-4713International Dial-in: 1-323-794-2093Conference Code: 8749633Webcast: http://public.viavid.com/index.php?id=143170 A telephone replay will be available approximately two hours after the call and will run through February 27, 2021 by dialing 1-844-512-2921 from the U.S., or 1-412-317-6671 from international locations, and entering replay pin number: 8749633. The replay can also be viewed through the webinar webcast link above. About Midwest Energy Emissions Corp. (ME2C®) Midwest Energy Emissions Corp. (OTCQB: MEEC) is a leading environmental technologies company delivering patented and proprietary solutions to the global power industry. ME2C’s leading-edge services have been shown to achieve emissions removal at a significantly lower cost and with less operational impact than currently used methods, while maintaining and/or increasing power plant output and preserving the marketability of byproducts for beneficial use. For more information, please visit www.midwestemissions.com. Safe Harbor Statement With the exception of historical information contained in this press release, content herein may contain "forward-looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified by using words such as "anticipate," "believe," "plan," "expect," "intend," "will," and similar expressions, but these words are not the exclusive means of identifying forward-looking statements. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. Matters that may cause actual results to differ materially from those in the forward-looking statements include, among other factors, the gain or loss of a major customer, change in environmental regulations, disruption in supply of materials, capacity factor fluctuations of power plant operations and power demands, a significant change in general economic conditions in any of the regions where our customer utilities might experience significant changes in electric demand, a significant disruption in the supply of coal to our customer units, the loss of key management personnel, availability of capital and any major litigation regarding ME2C. In addition, this release contains time-sensitive information that reflects management's best analysis only as of the date of this release. ME2C does not undertake any obligation to publicly update or revise any forward-looking statements to reflect future events, information or circumstances that arise after the date of this release. Further information concerning issues that could materially affect financial performance related to forward-looking statements contained in this release can be found in ME2C’s periodic filings with the Securities and Exchange Commission. ME2C Contact:Stacey HyattCorporate Communications Midwest Energy Emissions Corp. Main: 614-505-6115 x-1001Direct: firstname.lastname@example.org Investor Relations Contact: Greg Falesnik or Brooks Hamilton MZ Group - MZ North America 949-546-6326 MEEC@mzgroup.us www.mzgroup.us
Canadian home prices rose 0.6% in December from November, the strongest increase for a December since 2009, led by gains in Victoria, Halifax and Ottawa-Gatineau, data showed on Wednesday. The Teranet-National Bank Composite House Price Index, which tracks data collected from public land registries to measure changes for repeat sales of single-family homes, showed price gains in 10 of the 11 major metropolitan markets. Prices rose 1.3% in Victoria, 1.2% in Halifax and 1.2% in the national capital region of Ottawa-Gatineau.
TORONTO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the completion of a non-brokered private placement for aggregate gross proceeds of C$1,000,000 (the “Offering”) from the sale of common shares (“Common Shares”) at a price of C$0.065 per Common Share. The Offering was led by FLA Ventures Ltd. (“FLA Ventures”), a private equity fund based in Buenos Aires, Argentina, which focuses on investments in established and growth-oriented Latin American businesses across a range of sectors, seeking to create and add strategic value, driving their economic growth and enhancing their performances. Blueberries is pleased to welcome FLA Ventures as a new strategic partner. FLA Ventures financial backers, directors and team members have a vast experience leading companies involved in the healthcare, media, and real estate industries internationally as well as extensive cannabis expertise and strategic investments in the cannabis sector globally. Amongst other strategic business involvements, shareholders of FLA Ventures own Grupo América, one of the largest media groups in Argentina, and have extensive additional strategic relationships through their direct involvement in the healthcare industry as owners of one of the largest networks of medical centers and other medical service businesses in Argentina and elsewhere in Latin America. In connection with the completion of the Offering, Facundo Garretón has been named Chairman and Interim Chief Executive Officer of the Company, and Sebastian Hochbaum has been appointed to the board of directors of the Company (the “Board”). “Blueberries has built an impressive company in Colombia and its sophisticated extraction capabilities will play an integral role within our global cannabis platform. I am confident that the involvement of FLA Ventures and its stakeholders will provide Blueberries with the opportunity to accelerate its growth and take advantage of the rapidly expanding cannabis markets in Latin America and around the world,” stated Sebastian Hochbaum. “This strategic investment is a tremendous accomplishment for Blueberries and positions the company for commercial success. The FLA Ventures team is comprised of some of the most successful and highly respected entrepreneurs and investors in Latin America who also have extensive involvement and expertise in the cannabis industry,” stated Facundo Garretón, Chairman and Interim Chief Executive Officer. “I am also looking forward to leading Blueberries as we strive to execute on a domestic and international business plan.” New Director and Officer Biographies Facundo Garreton, Chairman and Interim-Chief Executive Officer Mr. Garreton is a successful entrepreneur in the fields of innovation, technology and life sciences, and a former member of Congress in Argentina. His successful track record as an entrepreneur includes founding InvertirOnline.com, one of Latin America’s largest online brokerage firms, as well as founding and serving as director of SociaLab and Sistema B, the most important platform for social entrepreneurs in Latin America. Mr. Garreton also has strategic involvement with other cannabis companies including YVY Life Sciences in Uruguay and Flow Kana in California. Mr. Garreton is a director of various successful companies such as: YVY Life Sciences, Pachama.com, VU Security, Untech.bio, Bulltick, GoodPeople, Inipop.com and others. Also, he is an investor in companies such as ClaraFoods, TheNotCompany, Blue Planet Ecosystems, Memphis Meat, Cambridge Crops, Electro-Active Technologies (EAT), Unbox Robotics, Prellisbio.com and MycoWorks. Sebastian Hochbaum, Director Mr. Hochaum is currently director of Control Media S.A., a holding company, with investments in real estate, media, technology and food business. Mr. Hochbaum is a trained attorney, graduating with honors from Torcuato Di Tella University in Buenos Aires, Argentina. Following his graduation from law school, he served for two years with the federal criminal justice division in Argentina, until joining Pampa Energía, one of the largest oil and gas companies in Argentina where he focused on capital markets and M&A initiatives for one year. Following his departure from Pampa Energía, Mr. Hochbaum joined Salaverri, Burgio & Wetzler Malbrán, a legal firm based in Buenos Aires, specializing in M&A and debt and equity financing deals. The Company intends to use the proceeds from the Offering for inventory production, product commercialization, continued advancement of its extraction and processing facility and general working capital purposes. In connection with the strategic financing, Christian Toro has resigned as Chairman and Chief Executive Officer of the Company and has been replaced by Facundo Garretón who has been appointed as Chairman and Interim Chief Executive Officer. Previous directors Christian Toro, Fabio Valencia Cossio, Dr. Andres Vidal, Francisco Sole, Matthew Bajurny and Paola Castañeda have all stepped down from the Board. The Board is now comprised of the following four directors: Facundo Garretón (Chairman and Interim CEO), Patricio Villalba, Catherine Lathwell and Sebastian Hochbaum. A fifth director, to be nominated by FLA Ventures, will be appointed to the Board in due course. The Audit Committee of the Board has also been reconstituted to include Catherine Lathwell, Patricio Villalba and Facundo Garreton. The Company would like to thank these individuals for their contributions to Blueberries, leading the Company through its early growth phases to commercialization. The Company has granted 250,000 compensation shares as well as 1,750,000 options (the "Options") to Mr. Garreton and 500,000 Options to Mr. Hochbaum to purchase common shares in the capital of the Company, pursuant to the Company's stock option plan. The Options are exercisable at a price of $0.13 per share for a period of five years, subject to vesting. About Blueberries Medical Corp. Blueberries is a Latin American licensed producer of naturally grown premium quality cannabis with its primary operations ideally located in the Bogotá Savannah of central Colombia and operations currently being established in Argentina. The Company is led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis in Colombia. Blueberries’ combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products. Additional information about the Company is available at www.blueberriesmed.com. For more information, please contact: Facundo Garretón, Chairman and Interim Chief Executive OfficerE: email@example.com Ian Atacan, Chief Financial OfficerE: firstname.lastname@example.orgTel: +1 (416) 562 3220 Cautionary Note Regarding Forward-Looking InformationThis news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward looking statements relate, among other things, to: commencement of commercial production of CBD-dominant oils and products, successful implementation of full GMP standards at its extraction facility to allow for additional export potential to international markets, achieving additional milestones is contemplated, or at all, ability to expand distribution networks, ability to expand and upgrade the Company’s cultivation facilities in Colombia, internal expectations, expectations regarding the ability of the Company to access new Latin American and international markets, the ability to attract and retain new customers, and future expansion plans including development of the cultivation, production, industrialization and marketing of cannabis for commercial and scientific purposes.These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Colombian and international medical cannabis market and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in Colombia, Argentina and elsewhere; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law. Additional information regarding the Company, and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's Listing Statement dated January 31, 2019 filed on its issuer profile on SEDAR at www.sedar.com. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
Company intends to focus on opportunities in the psychedelic space in the Caribbean and distribute Global 20/20 shares at a later date.MIAMI, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics, announced today the Company has closed the transaction to sell 100% of its Mycotopia Therapy subsidiary to 20/20 Global Inc. (OTC Pink: TWGL). As a result of the transaction closing, Ehave controls approximately 75.77% of the outstanding shares of 20/20 Global. 20/20 Global Inc. plans to file with FINRA to change the name of the company to Mycotopia Therapy. Ehave, Inc. and 20/20 Global will file applicable 8k and 6k filings for the transaction with the SEC and SEDAR. Ehave Chairman and CEO Ben Kaplan will serve as Chairman and CEO of both Ehave and 20/20 Global. All payments have been made and stock certificates transferred to complete the transaction. In the future, Ehave management intends to present a plan to the Board to provide its shareholders an opportunity to participate in the transaction. Details of the distribution of shares will be provided at a later date when details are available. The Board of Directors of 20/20 Global has stepped down and Ben Kaplan has been named CEO of Global 20/20, as well as Ehave, Inc. In addition to Mr. Kaplan, Mark Croskery has been appointed to the Board of Directors of 20/20 Global. In addition to his responsibilities to the Board of 20/20 Global, Mr. Croskery serves as Chairman and CEO of Croskery Capital Limited in Kingston, Jamaica. The transaction has been well received in Jamaica and was the subject of an article in the Jamaica Gleaner, a leading Jamaican newspaper that has been published since 1834. The article titled "Ehave Magic Mushroom Company To Enter Jamaica - Taps Croskery As Director Of Subsidiary, Kaya As Wellness Adviser And Partner" can be found at http://jamaica-gleaner.com/article/business/20210115/ehave-magic-mushroom-company-enter-jamaica-taps-croskery-director. 20/20 Global and Mycotopia Therapies will be a pure play on the psychedelic space and own 10% of PsyTech, which produces of the psychedelic professional conferences regarding the science of psychedelics and related business opportunities company along with psychedelic tour and travel related businesses. Ehave will continue develop Ketadash, the Ehave Dashboard, its MegaTeam video game applications for children with ADHD, the safety and security of Electronic Health Records (EHRs), improving mental health, and combatting mental illness. Ehave CEO Ben Kaplan said "We look forward to developing Mycotopia’s business plan as a stand-alone public company. Our goal is to expand the presence of both Ehave and 20/20 Global as separate ecosystems in the psychedelic sector and continue to develop new opportunities." Mr. Kaplan continued, "We also plan to distribute some of the 20/20 Global shares held by Ehave to its shareholders. We are considering several options and will provide more information once we have ascertained the most beneficial method of distribution for our shareholders." Additional Ehave Inc. Information We are truly grateful for the support of EHVVF shareholders! Please join the conversation on our Ehave supporter’s telegram group at https://t.me/EhaveInc. The company posts important information and updates through weekly videos from the official company YouTube channel https://www.youtube.com/channel/UCnyW1mgMd0qmYkEMq3O6FWA. Please follow Ehave on Twitter @Ehaveinc1 About Ehave, Inc. Ehave, Inc. (EHVVF) is a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients. Our primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes. Our main product is the Ehave Telemetry Portal, which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insights. The Ehave Infinity Portal offers a powerful machine learning and artificial intelligence platform with a growing set of advanced tools and applications developed by Ehave and its leading partners. This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools. Additional information on Ehave can be found on the Company’s website at: www.ehave.com. About Mycotopia Therapy Mycotopia Therapy focuses on helping you heal and reclaim your life. Your journey of healing is an understanding of the causes and works to mental wellness through psychedelic enhanced psychotherapy, integrated with a professional team of mental wellness practitioners and cutting-edge technology. Psychedelic therapy is a holistic and spiritual approach providing healing and has shown successful treatment for many years. Additional information on Mycotopia Therapy can be found on the Company’s website at: https://www.mycotopiatherapies.com. Forward-Looking Statement Disclaimer This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is contained under the heading "Risk Factors" in Ehave, Inc.’s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC's website, http://www.sec.gov. Contact for Ehave Inc and 20/20 Global Media Inquiries: Gabe Rodriguez Gabe@Ehave.com Investor Relations: Email: Ir@Ehave.com Phone: (623) 261-9046
Chatham Lodging Announces Fourth Quarter Earnings Call to be Held on Wednesday, February 24, 2021
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) provided today details of its plans to report fourth quarter 2020 financial results on February 3, 2021. Ligand’s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call.
SHENZHEN, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Taoping Inc. (NASDAQ: TAOP, the “Company”), a provider of internet-based smart display screens, and a new-media ecosystem that enables targeted advertising and online retail, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors (the “Investors”) on January 19, 2021. Pursuant to the Purchase Agreement, the Company agreed to sell to the Investors an aggregate of 740,740 ordinary shares, no par value (the “Ordinary Shares”) at a purchase price of $2.7 per share, in a registered direct offering. The gross proceeds to the Company from the financing are approximately $2.0 million before deducting estimated offering expenses. For more details of the financing, please see the Company’s Report on Form 6-K to be filed on or about January 21, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. “We appreciate the Investors’ confidence in our management team and growth strategy, and will continue to serve customers well and create long-term value for shareholders," said Mr. Jianghuai Lin, Chairman and CEO of TAOP. About Taoping Inc. Taoping Inc. (TAOP), is a leading provider of smart display terminals for targeted advertising and online retail. The Company provides integrated end-to-end digital advertising solutions enabling customers to distribute and manage advertisements on advertisement display terminals. Connecting cloud-based advertisement terminal owners, advertisers and consumers, it builds up a resource sharing "Smart IoT Terminal - Taoping Net/ App - Taoping Go (e-Store)" media ecosystem to ultimately achieve the mission "our technology makes advertising and branding affordable and effective for everyone." To learn more, please visit http://www.taop.com/. Safe Harbor Statement This press release may contain certain "forward-looking statements" relating to the business of Taoping Inc., and its subsidiaries and other consolidated entities. All statements, other than statements of historical fact included herein, are "forward-looking statements" in nature within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, often identified by the use of forward-looking terminologies such as "believes", "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company and its subsidiaries and other consolidated entities or persons acting on their behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements. For further information, please contact: Taoping Inc.Chang QiuEmail: email@example.com://www.taop.com/or Dragon Gate Investment Partners LLCTel: +1(646)-801-2803Email: firstname.lastname@example.org
NEWARK, N.Y., Jan. 20, 2021 (GLOBE NEWSWIRE) -- IEC Electronics Corp. (Nasdaq: IEC) today announced that it will host a conference call on Wednesday, February 3, 2021 at 10:00 a.m. Eastern Time, to discuss its financial results for the fiscal first quarter of 2021, ended December 31, 2020. The conference call may be accessed in the U.S. and Canada by dialing toll-free (877) 407-9210. International callers may access the call by dialing (201) 689-8049. A replay of the teleconference will be available for 30 days after the call and may be accessed domestically by dialing (877) 481-4010 and international callers may dial (919) 882-2331. Callers must enter conference ID: 39521. To access the live webcast, log onto the IEC website at http://www.iec-electronics.com. The webcast can also be accessed at https://www.webcaster4.com/Webcast/Page/2149/39521. An online replay will be available shortly after the call. About IEC Electronics IEC Electronics is a provider of electronic manufacturing services ("EMS") to advanced technology companies that produce life-saving and mission critical products for the medical, industrial, aerospace and defense sectors. The Company specializes in delivering technical solutions for the custom manufacture of complex full system assemblies by providing on-site analytical testing laboratories, custom design and test engineering services combined with a broad array of manufacturing services encompassing electronics, interconnect solutions, and precision metalworking. As a full service EMS provider, IEC holds all appropriate certifications for the market sectors it supports including ISO 9001:2008, AS9100D, ISO 13485, and Nadcap. IEC Electronics is headquartered in Newark, NY and also has operations in Rochester, NY and Albuquerque, NM. Additional information about IEC can be found on its web site at www.iec-electronics.com. Company Contact:Tom BarbatoSenior Vice President & Chief Financial OfficerIEC Electronics315.email@example.com Agency Contact:John Nesbett/Jennifer BelodeauIMS Investor Relations203.firstname.lastname@example.org
Centro Benefits Research, LLC today announced it has named Treg Balding Chief Operating Officer. As the former Vice President of Distribution and Client Management at Guardian Life, Balding brings over 32 years of industry experience to this role. Balding will be responsible for revenue growth, distribution management, carrier relationships, and will be a catalyst for the already dynamic growth engine of Centro.
New findings reveal retail and hospitality sector fixes software vulnerabilities faster than other sectors, but has room to improve with DevSecOps.
SPOT LLC, a wholly-owned subsidiary of Globalstar, Inc. (NYSE American: GSAT) and leader in satellite messaging and emergency notification technologies, today announced its partnership with monthly subscription box service, Battlbox. As part of the partnership, Battlbox Pro Box subscribers will receive a SPOT Gen4, the next generation of the SPOT Satellite GPS Messenger™, with up to 6 months of service.
Charles River Laboratories schedules fourth-quarter 2020 earnings and 2021 guidance release and conference call.
Repay Holdings Corporation (NASDAQ: RPAY) ("REPAY"), a leading provider of vertically-integrated payment solutions, today announced a technology integration with Billtrust (NASDAQ: BTRS), a B2B accounts receivable automation and integrated B2B payments leader. Through REPAY’s participation in Billtrust’s Business Payments Network (BPN), REPAY’s corporate customers will instantly gain the ability to automate electronic payments to Billtrust’s vast network of suppliers, distributors and vendors – both accelerating and simplifying the payment process, while also further scaling adoption of virtual credit cards.
Fort Point Capital ("Fort Point"), a leading private equity firm focused on investing in service-oriented companies in the lower middle market, announced today that it has completed fundraising for FPC Small Cap Fund II ("the Fund"). The Fund will enable Fort Point to continue its investment approach of partnering with management teams and entrepreneurs to build market-leading business-to-business services companies. Since the firm’s inception in 2010, Fort Point Capital has raised close to $300 million in equity commitments across various investing entities and has invested in 10 platform companies and 15 add-on acquisitions.
Transcat (Nasdaq: TRNS) Announces Third Quarter Fiscal Year 2021 Conference Call and Webcast
Berkley One increases depth and breadth of footprint with new state launches.